betamethasone-17,21-dipropionate has been researched along with cephalexin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barrick, CJ; Ermolovich, T; Lountzis, NI; Onikoyi, O; Purcell, SM | 1 |
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
2 other study(ies) available for betamethasone-17,21-dipropionate and cephalexin
| Article | Year |
|---|---|
Necrobiosis lipoidica with superimposed pyoderma vegetans.
Topics: Adult; Anti-Bacterial Agents; Anti-Inflammatory Agents; Betamethasone; Cephalexin; Female; Humans; Mupirocin; Necrobiosis Lipoidica; Pyoderma; Skin Diseases, Bacterial | 2019 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |